Healthcare

The convergence of artificial intelligence and biological intelligence is reshaping modern healthcare, redefining how diseases are diagnosed, treated and prevented. By combining machine learning systems with deep biological insights, healthcare providers are moving toward more precise, predictive and personalized care models. From early disease detection and drug discovery to robotic surgery and patient monitoring, AI-driven tools are augmenting clinical decision-making rather than replacing it.

Apollo Hospitals Enterprise Ltd. reported a robust 35% year-on-year rise in consolidated net profit to Rs 502 crore for the third quarter, reflecting resilient demand across its hospital network, pharmacy operations and digital health platforms. Revenue growth was underpinned by higher occupancy rates, improved case mix and steady traction in specialized treatments. The performance underscores the structural strength of India’s private healthcare sector, driven by rising health awareness, insurance penetration and capacity expansion.

Dr. Agarwal’s Health Care, a leading chain in ophthalmology and healthcare services, reported a profit after tax (PAT) of Rs 44 crore in Q3 FY26, reflecting a steady financial performance amid a challenging healthcare environment. The company’s revenue growth was driven by increased patient inflows across its clinics and surgical centers, coupled with efficient cost management strategies. Analysts note that Dr. Agarwal’s continued focus on expanding its network, enhancing service offerings, and adopting innovative healthcare technologies positions the company well for sustainable growth.

Practo, a leading digital healthcare platform, has announced its expansion into the United States, signaling a significant step in its global growth journey. The move reflects the company’s ambition to tap into one of the world’s most advanced and competitive healthcare ecosystems. By leveraging its technology-driven care delivery model, Practo aims to streamline interactions between patients, providers, and healthcare systems. Industry observers see the expansion as a calculated bet on scalable digital health solutions amid rising healthcare costs and demand for efficiency. The U.S.

Granules India has received regulatory approval from U.S. authorities for a medication used in the treatment of Attention Deficit Hyperactivity Disorder, marking a notable milestone in the company’s international growth strategy. The clearance enables the pharmaceutical manufacturer to expand its presence in the world’s largest drug market while reinforcing its reputation as a reliable supplier of complex generics. Industry analysts view the development as a positive signal for Granules India’s revenue visibility, given the steady demand for central nervous system therapies.

Fittr, a digital fitness and nutrition platform best known for its coaching-led wellness model, has entered the preventive healthcare space with the launch of diagnostic laboratory services. The move marks a strategic expansion beyond fitness into early detection and data-driven health management. By integrating diagnostics with personalized coaching, Fittr aims to address lifestyle-related conditions before they escalate into chronic illnesses.

Mits Healthcare’s initial public offering marks a pivotal step in the company’s long-term growth strategy, with expansion and capacity enhancement at the core of its plans. The pharmaceutical manufacturer aims to leverage fresh capital to scale operations, strengthen its product portfolio, and widen its market reach in both domestic and export markets. The IPO comes at a time when demand for affordable and quality healthcare products is rising steadily.

Fortis Healthcare has strengthened its presence in southern India through the acquisition of People Tree Hospital for Rs. 430 crore, signaling a renewed push toward strategic expansion in high-growth urban healthcare markets. The transaction aligns with Fortis’ long-term strategy of scaling capacity through targeted acquisitions rather than greenfield projects. By integrating a well-established tertiary care facility into its network, Fortis aims to enhance patient reach, operational synergies and clinical depth.

Nephrocare’s shares opened on a strong note in their stock market debut, signaling positive investor confidence in the healthcare company’s growth prospects and business fundamentals. The listing performance reflected healthy demand from both institutional and retail investors, supported by optimism around India’s expanding healthcare sector and rising focus on specialized medical services. Market participants viewed the debut as a validation of Nephrocare’s operating model, financial discipline and long-term potential.

Fortis Healthcare has strengthened its clinical offerings with the launch of a specialized mental healthcare facility, marking a significant step toward addressing India’s growing mental health needs. The new center is designed to provide comprehensive, patient-centric care for a wide range of psychological and psychiatric conditions. By integrating medical expertise, therapeutic support and modern infrastructure, Fortis aims to reduce the treatment gap in mental health services.